Bunavail

Pain, Itching, Septic Shock + 7 more
Treatment
8 FDA approvals
15 Active Studies for Bunavail

What is Bunavail

NaloxoneThe Generic name of this drug
Treatment SummaryNaloxone is a medication that blocks or reverses the effects of opioid drugs. It is used to treat drug overdoses caused by opioids such as morphine, hydromorphone, methadone, heroin, and fentanyl. It works by binding to opioid receptors in the body and blocking the effects of other drugs bound to those receptors. Common symptoms of an opioid overdose include trouble breathing, slow heart rate, slurred speech, drowsiness, and constricted pupils. If not treated, this can lead to vomiting, no pulse or breathing, loss of consciousness and even death. Naloxone can be given by intram
Narcanis the brand name
image of different drug pills on a surface
Bunavail Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Narcan
Naloxone
1971
241

Approved as Treatment by the FDA

Naloxone, otherwise called Narcan, is approved by the FDA for 8 uses including Pain and Opioid Dependence .
Pain
Used to treat moderate Pain in combination with Pentazocine
Opioid Dependence
Used to treat Opioid Dependence in combination with Buprenorphine
Septic Shock
Pain
Used to treat Severe Pain in combination with Pentazocine
Opioid-Related Disorders
Used to treat Opioid Dependence in combination with Buprenorphine
Septic Shock
Opioids
Respiratory Insufficiency

Effectiveness

How Bunavail Affects PatientsNaloxone is a medication that is used to reverse the effects of an opioid overdose. It works quickly but may need to be taken multiple times. It is safe to take even if the person has not taken opioids, but they may experience withdrawal symptoms. It is important to note that naloxone may not completely fix all symptoms if the person has also taken other drugs.
How Bunavail works in the bodyNaloxone is a drug that blocks the effects of opioids in the body. It binds to the opioid receptors, preventing opioids from binding and blocking their effects. If someone has not taken opioids, naloxone will not have any effect.

When to interrupt dosage

The advised measure of Bunavail is dependent upon the determined condition, including Opioid Dependence, Pain and Septic Shock. The dosage differs, depending on the technique of delivery (e.g. Spray, metered or Tablet) specified in the table below.
Condition
Dosage
Administration
Respiratory Insufficiency
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Opioids
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Pain
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Pain
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Opioid-Related Disorders
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Opioids
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Itching
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Septic Shock
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Emergency Care
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal
Opioids
, 0.4 mg/mL, 1.0 mg/mL, 0.5 mg, 2.0 mg, 0.4 mg, 40.0 mg/mL, 4.0 mg, 20.0 mg/mL, 5.0 mg, 10.0 mg, 20.0 mg, 2.5 mg, 1.0 mg, 3.0 mg, 2.9 mg, 0.36 mg, 0.71 mg, 1.4 mg, 2.1 mg, 0.18 mg, 0.7 mg, 0.3 mg, 4.0 mg/mL, 0.02 mg/mL, 1.8 mg, 80.0 mg/mL, 50.0 mg/mL
, Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Parenteral, Injection, Injection - Parenteral, Injection - Intramuscular; Intravenous; Subcutaneous, Oral, Tablet, Tablet - Oral, Sublingual, Tablet - Sublingual, Film, soluble, Film, soluble - Sublingual, Intramuscular; Subcutaneous, Injection, solution - Intramuscular; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Solution, Solution - Intramuscular; Intravenous; Subcutaneous, Nasal, Spray, Spray - Nasal, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Sublingual, Spray, metered, Spray, metered - Nasal, Buccal, Film, Film - Buccal, Pill - Sublingual, Pill, Buccal; Sublingual, Film, soluble - Buccal; Sublingual, Film - Buccal; Sublingual, Intravenous, Injection - Intravenous, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Parenteral; Topical, Inhalant, Inhalant - Nasal

Warnings

Bunavail has one contraindication, so it should not be used when someone experiences any of the conditions listed in the table below.Bunavail Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Naloxone may interact with Pulse Frequency
There are 20 known major drug interactions with Bunavail.
Common Bunavail Drug Interactions
Drug Name
Risk Level
Description
(R)-warfarin
Major
The metabolism of (R)-warfarin can be decreased when combined with Naloxone.
(S)-Warfarin
Major
The metabolism of (S)-Warfarin can be decreased when combined with Naloxone.
1,2-Benzodiazepine
Major
The metabolism of 1,2-Benzodiazepine can be decreased when combined with Naloxone.
3,5-diiodothyropropionic acid
Major
The metabolism of 3,5-diiodothyropropionic acid can be decreased when combined with Naloxone.
5-androstenedione
Major
The metabolism of 5-androstenedione can be decreased when combined with Naloxone.
Bunavail Toxicity & Overdose RiskIf a patient hasn't taken opioids, naloxone won't have much of an effect. The toxic dose of naloxone in mice is higher than 1g/kg when taken orally, 80mg/kg when given through the abdomen, and 286mg/kg when given through the skin. The toxic dose in rats is higher than 1g/kg when taken orally, 239mg/kg when given through the abdomen, and 500mg/kg when given through the skin.
image of a doctor in a lab doing drug, clinical research

Bunavail Novel Uses: Which Conditions Have a Clinical Trial Featuring Bunavail?

64 active trials are being conducted to investigate Bunavail's potential as a therapeutic agent for Opioids, Opioids-Induced Pain and other associated conditions.
Condition
Clinical Trials
Trial Phases
Emergency Care
0 Actively Recruiting
Opioids
0 Actively Recruiting
Opioid-Related Disorders
0 Actively Recruiting
Septic Shock
0 Actively Recruiting
Respiratory Insufficiency
0 Actively Recruiting
Itching
3 Actively Recruiting
Phase 2, Phase 3, Not Applicable
Pain
0 Actively Recruiting
Opioids
7 Actively Recruiting
Phase 4, Not Applicable, Phase 2, Phase 1
Opioids
6 Actively Recruiting
Phase 4, Phase 2, Not Applicable, Early Phase 1
Pain
0 Actively Recruiting

Bunavail Reviews: What are patients saying about Bunavail?

5Patient Review
2/23/2015
Bunavail for Narcotic Addiction
I've been addicted to pills and heroin for over a decade, and this is by far the best treatment I've tried. Methadone and suboxone didn't work as well for me, and I find that this treatment doesn't have any horrible after taste or cravings. I'm also using half the amount of suboxone, which is great.
5Patient Review
12/20/2016
Bunavail for Narcotic Addiction
I found that this drug absorbed quicker than Suboxone and required less mg to be effective. From reading the negative reviews, it's obvious that these people either didn't give it a chance or aren't actually trying to get better. Bunavail works great for me.
5Patient Review
10/30/2015
Bunavail for Chronic Pain
Super easy to use and really quick-acting.
3Patient Review
2/26/2015
Bunavail for Narcotic Addiction
I wasn't as impressed with this drug as I was with suboxone. It takes a while to work- sometimes up to 45 minutes- and even then I still have to spit it out. Suboxone just seems to do a better job at managing cravings and pain.
2.7Patient Review
12/29/2014
Bunavail for Narcotic Addiction
I'm not sure if this drug is effective yet. I took it today for the first time and now I have a headache and feel jittery. I don't want to get addicted to another medication, so I'm going to talk to my doctor about it tomorrow.
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about bunavail

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Bunavail the same as Suboxone?

"The main differences between Bunavail and Suboxone are: -Bunavail is more easily and completely absorbed into the bloodstream. -Suboxone is considered to be approximately twice as strong as Bunavail."

Answered by AI

What is Bunavail buccal film?

"BUNAVAIL is a yellow, rectangular film that is citrus-flavored and is intended to be applied to the buccal mucosa. The film has ink markings on the mucoadhesive side."

Answered by AI

What is Bunavail used for?

"Naloxone blocks the effects of opioids at the opioid receptors, and reverses the respiratory depression caused by buprenorphine.

This medication is a combination of buprenorphine and naloxone, and is used to treat opioid dependence or addiction. Buprenorphine is a drug that belongs to a class of mixed opioid agonist-antagonists, and helps to prevent withdrawal symptoms that can occur when other opioids are stopped. Naloxone is a drug that blocks the effects of opioids at the opioid receptors, and also reverses the respiratory depression that buprenorphine can cause."

Answered by AI

Is Bunavail still available?

"BioDelivery Sciences International, Inc. is discontinuing its drug Bunavail in the United States as of March 2020."

Answered by AI

Clinical Trials for Bunavail

Have you considered Bunavail clinical trials? We made a collection of clinical trials featuring Bunavail, we think they might fit your search criteria.
Have you considered Bunavail clinical trials? We made a collection of clinical trials featuring Bunavail, we think they might fit your search criteria.
Have you considered Bunavail clinical trials? We made a collection of clinical trials featuring Bunavail, we think they might fit your search criteria.